| |
| |
|
| Insider
Information: |
Mp 13 Ventures, Llc |
| Relationship: |
|
| City: |
Cardiff-By-The-Sea |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
31,649,699 |
|
|
Indirect Shares
|
80,497,085 |
|
|
| Direct
Value |
$250,107,837 |
|
|
|
Indirect Value
|
$122,178,232 |
|
|
| Total
Shares |
112,146,784 |
|
|
| Total
Value |
$372,286,069 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
2
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
1
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 93.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
ImmunityBio, Inc |
IBRX |
10% Owner |
2021-03-09 |
29,473,932 |
2021-03-09 |
13,694,485 |
Premium* |
|
|
Sorrento Therapeutics Inc |
SRNE |
Reporting group member |
2016-06-29 |
720,174 |
2016-07-07 |
0 |
Premium* |
|
|
Nanthealth Inc |
NH |
10% Owner |
2021-04-13 |
0 |
2021-04-13 |
66,802,600 |
Premium* |
|
|
Heliogen, Inc |
HLGN.U |
|
2024-02-15 |
1,455,593 |
2024-02-15 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
22 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HLGN.U |
Heliogen, Inc |
|
– – • |
2024-02-15 |
4 |
B |
$1.52 |
$672,072 |
D/D |
442,298 |
442,298 |
0.01 |
- |
|
| NH |
Nanthealth Inc |
Chief Executive Officer |
– – • |
2021-04-13 |
4 |
B |
$2.96 |
$4,999,999 |
I/I |
1,689,189 |
1,689,189 |
1.5 |
% |
|
| IBRX |
ImmunityBio, Inc |
Executive Chairman |
– – • |
2021-03-09 |
4 |
A |
$0.00 |
$0 |
D/D |
5,723,182 |
29,473,932 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Executive Chairman |
– – • |
2021-03-09 |
4 |
A |
$0.00 |
$0 |
I/I |
237,489,573 |
7,976,159 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chairman and CEO |
– – • |
2020-06-29 |
4 |
B |
$12.12 |
$44,965,200 |
D/D |
3,710,000 |
23,750,750 |
2.45 |
% |
|
| IBRX |
ImmunityBio, Inc |
Chairman and CEO |
– – • |
2019-03-21 |
4 |
OE |
$2.20 |
$4,070,152 |
D/D |
1,851,500 |
20,040,750 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chairman and CEO |
– – • |
2019-03-21 |
4 |
A |
$2.00 |
$35,150,357 |
D/D |
17,589,250 |
18,189,250 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chairman and CEO |
– – • |
2018-07-11 |
4 |
OE |
$1.62 |
$15,000 |
I/I |
9,257 |
40,565,814 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chairman and CEO |
– – • |
2016-12-30 |
4 |
GD |
$0.00 |
$0 |
I/I |
450,000 |
40,556,557 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Reporting group member |
– – – |
2016-07-07 |
4 |
S |
$0.00 |
$0 |
I/I |
(7,878,098) |
0 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Reporting group member |
– – – |
2016-06-29 |
4 |
S |
$5.82 |
$19,785 |
I/I |
(3,400) |
7,157,924 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Reporting group member |
– – – |
2016-06-23 |
4 |
S |
$5.85 |
$40,398 |
I/I |
(6,901) |
7,161,324 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Reporting group member |
– – – |
2016-06-15 |
4 |
S |
$5.87 |
$116,477 |
I/I |
(19,836) |
7,168,225 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Reporting group member |
– – – |
2016-06-14 |
4 |
S |
$6.11 |
$97,653 |
D/D |
(15,972) |
720,174 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Reporting group member |
– – – |
2016-06-13 |
4 |
S |
$6.15 |
$232,232 |
D/D |
(37,792) |
736,146 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Reporting group member |
– – • |
2016-03-07 |
4 |
S |
$6.17 |
$526,301 |
D/D |
(85,300) |
773,938 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Reporting group member |
– – • |
2016-03-04 |
4 |
S |
$6.34 |
$93,198 |
D/D |
(14,700) |
859,238 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chairman and CEO |
– – • |
2015-08-21 |
4 |
B |
$23.00 |
$10,350,000 |
I/I |
450,000 |
41,016,557 |
1.5 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Reporting group member |
– – – |
2015-07-28 |
4 |
GA |
$0.00 |
$0 |
I/I |
720,174 |
7,878,098 |
0 |
- |
|
| SRNE |
Sorrento Therapeutics Inc |
Reporting group member |
– – – |
2015-07-28 |
4 |
GD |
$0.00 |
$0 |
D/D |
720,174 |
0 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chairman and CEO |
– – • |
2015-07-27 |
4 |
A |
$0.00 |
$0 |
D/D |
600,000 |
600,000 |
0 |
- |
|
| IBRX |
ImmunityBio, Inc |
Chairman and CEO10% Owner |
– – • |
2015-07-27 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
40,566,557 |
|
- |
|
22 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
